Literature DB >> 19171938

Functional Interactions between Distinct Sodium Channel Cytoplasmic Domains through the Action of Calmodulin.

Franck Potet1, Benjamin Chagot, Mircea Anghelescu, Prakash C Viswanathan, Svetlana Z Stepanovic, Sabina Kupershmidt, Walter J Chazin, Jeffrey R Balser.   

Abstract

Sodium channels are fundamental signaling molecules in excitable cells, and are molecular targets for local anesthetic agents and intracellular free Ca(2+) ([Ca(2+)](i)). Two regions of Na(V)1.5 have been identified previously as [Ca(2+)](i)-sensitive modulators of channel inactivation. These include a C-terminal IQ motif that binds calmodulin (CaM) in different modes depending on Ca(2+) levels, and an immediately adjacent C-terminal EF-hand domain that directly binds Ca(2+). Here we show that a mutation of the IQ domain (A1924T; Brugada Syndrome) that reduces CaM binding stabilizes Na(V)1.5 inactivation, similarly and more extensively than even reducing [Ca(2+)](i). Because the DIII-DIV linker is an essential structure in Na(V)1.5 inactivation, we evaluated this domain for a potential CaM binding interaction. We identified a novel CaM binding site within the linker, validated its interaction with CaM by NMR spectroscopy, and revealed its micromolar affinity by isothermal titration calorimetry. Mutation of three consecutive hydrophobic residues (Phe(1520)-Ile(1521)-Phe(1522)) to alanines in this CaM-binding domain recapitulated the electrophysiology phenotype observed with mutation of the C-terminal IQ domain: Na(V)1.5 inactivation was stabilized; moreover, mutations of either CaM-binding domain abolish the well described stabilization of inactivation by lidocaine. The direct physical interaction of CaM with the C-terminal IQ domain and the DIII-DIV linker, combined with the similarity in phenotypes when CaM-binding sites in either domain are mutated, suggests these cytoplasmic structures could be functionally coupled through the action of CaM. These findings have bearing upon Na(+) channel function in genetically altered channels and under pathophysiologic conditions where [Ca(2+)](i) impacts cardiac conduction.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19171938      PMCID: PMC2659242          DOI: 10.1074/jbc.M806871200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  39 in total

1.  Role of the C-terminal domain in inactivation of brain and cardiac sodium channels.

Authors:  M Mantegazza; F H Yu; W A Catterall; T Scheuer
Journal:  Proc Natl Acad Sci U S A       Date:  2001-12-11       Impact factor: 11.205

2.  Isoform-specific modulation of voltage-gated Na(+) channels by calmodulin.

Authors:  Isabelle Deschênes; Nathalie Neyroud; Deborah DiSilvestre; Eduardo Marbán; David T Yue; Gordon F Tomaselli
Journal:  Circ Res       Date:  2002-03-08       Impact factor: 17.367

3.  A calcium sensor in the sodium channel modulates cardiac excitability.

Authors:  Hanno L Tan; Sabina Kupershmidt; Rong Zhang; Svetlana Stepanovic; Dan M Roden; Arthur A M Wilde; Mark E Anderson; Jeffrey R Balser
Journal:  Nature       Date:  2002-01-24       Impact factor: 49.962

4.  Biophysical phenotypes of SCN5A mutations causing long QT and Brugada syndromes.

Authors:  G Baroudi; M Chahine
Journal:  FEBS Lett       Date:  2000-12-29       Impact factor: 4.124

5.  A sodium-channel mutation causes isolated cardiac conduction disease.

Authors:  H L Tan; M T Bink-Boelkens; C R Bezzina; P C Viswanathan; G C Beaufort-Krol; P J van Tintelen; M P van den Berg; A A Wilde; J R Balser
Journal:  Nature       Date:  2001-02-22       Impact factor: 49.962

6.  A revised view of cardiac sodium channel "blockade" in the long-QT syndrome.

Authors:  N G Kambouris; H B Nuss; D C Johns; E Marbán; G F Tomaselli; J R Balser
Journal:  J Clin Invest       Date:  2000-04       Impact factor: 14.808

7.  Spectrum of mutations in long-QT syndrome genes. KVLQT1, HERG, SCN5A, KCNE1, and KCNE2.

Authors:  I Splawski; J Shen; K W Timothy; M H Lehmann; S Priori; J L Robinson; A J Moss; P J Schwartz; J A Towbin; G M Vincent; M T Keating
Journal:  Circulation       Date:  2000-09-05       Impact factor: 29.690

8.  Gating-dependent mechanisms for flecainide action in SCN5A-linked arrhythmia syndromes.

Authors:  P C Viswanathan; C R Bezzina; A L George; D M Roden; A A Wilde; J R Balser
Journal:  Circulation       Date:  2001-09-04       Impact factor: 29.690

9.  Cardiac sodium channel mutation in atrial fibrillation.

Authors:  Patrick T Ellinor; Edwin G Nam; Marisa A Shea; David J Milan; Jeremy N Ruskin; Calum A MacRae
Journal:  Heart Rhythm       Date:  2007-09-19       Impact factor: 6.343

10.  A structural rearrangement in the sodium channel pore linked to slow inactivation and use dependence.

Authors:  B H Ong; G F Tomaselli; J R Balser
Journal:  J Gen Physiol       Date:  2000-11       Impact factor: 4.086

View more
  44 in total

Review 1.  A novel mechanism for the treatment of angina, arrhythmias, and diastolic dysfunction: inhibition of late I(Na) using ranolazine.

Authors:  Lars S Maier
Journal:  J Cardiovasc Pharmacol       Date:  2009-10       Impact factor: 3.105

2.  A computational kinetic model of diffusion for molecular systems.

Authors:  Ivan Teo; Klaus Schulten
Journal:  J Chem Phys       Date:  2013-09-28       Impact factor: 3.488

3.  Sodium channel carboxyl-terminal residue regulates fast inactivation.

Authors:  Hai M Nguyen; Alan L Goldin
Journal:  J Biol Chem       Date:  2010-01-20       Impact factor: 5.157

4.  Relating form and function of EF-hand calcium binding proteins.

Authors:  Walter J Chazin
Journal:  Acc Chem Res       Date:  2011-02-11       Impact factor: 22.384

Review 5.  Late sodium current: A mechanism for angina, heart failure, and arrhythmia.

Authors:  Jonathan C Makielski
Journal:  Trends Cardiovasc Med       Date:  2015-05-22       Impact factor: 6.677

6.  A rendezvous with the queen of ion channels: Three decades of ion channel research by David T Yue and his Calcium Signals Laboratory.

Authors:  Ivy E Dick; Worawan B Limpitikul; Jacqueline Niu; Rahul Banerjee; John B Issa; Manu Ben-Johny; Paul J Adams; Po Wei Kang; Shin Rong Lee; Lingjie Sang; Wanjun Yang; Jennifer Babich; Manning Zhang; Hojjat Bazazzi; Nancy C Yue; Gordon F Tomaselli
Journal:  Channels (Austin)       Date:  2015-07-15       Impact factor: 2.581

7.  Crystal structures of Ca2+-calmodulin bound to NaV C-terminal regions suggest role for EF-hand domain in binding and inactivation.

Authors:  Bernd R Gardill; Ricardo E Rivera-Acevedo; Ching-Chieh Tung; Filip Van Petegem
Journal:  Proc Natl Acad Sci U S A       Date:  2019-05-09       Impact factor: 11.205

8.  Genetic engineering of somatic cells to study and improve cardiac function.

Authors:  Robert D Kirkton; Nenad Bursac
Journal:  Europace       Date:  2012-11       Impact factor: 5.214

9.  Calmodulin mutations associated with recurrent cardiac arrest in infants.

Authors:  Lia Crotti; Christopher N Johnson; Elisabeth Graf; Gaetano M De Ferrari; Bettina F Cuneo; Marc Ovadia; John Papagiannis; Michael D Feldkamp; Subodh G Rathi; Jennifer D Kunic; Matteo Pedrazzini; Thomas Wieland; Peter Lichtner; Britt-Maria Beckmann; Travis Clark; Christian Shaffer; D Woodrow Benson; Stefan Kääb; Thomas Meitinger; Tim M Strom; Walter J Chazin; Peter J Schwartz; Alfred L George
Journal:  Circulation       Date:  2013-02-06       Impact factor: 29.690

Review 10.  Cardiac sodium channelopathies.

Authors:  Ahmad S Amin; Alaleh Asghari-Roodsari; Hanno L Tan
Journal:  Pflugers Arch       Date:  2009-11-29       Impact factor: 3.657

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.